Factors associated with exacerbation in mild-to-moderate COPD patients

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 1327-1333

  Kim, Joo Kyung ^a   Lee, Soo Haeng ^a   Lee, Bho Hyeon ^a   Lee, Chang Youl ^a   Kim, Do Jin ^b   Min, Kyung Hoon ^c   Kim, Sung Kyoun ^d   Yoo, Kwang Ha ^e   Jung, Ki Suck ^a   Hwang, Yong Il ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Konkuk University Hospital   (South Korea)

Author keywords

COPD; Exacerbation; Risk factors

Indexed keywords

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PNEUMONIA; QUALITY OF LIFE; RESPIRATORY TRACT PARAMETERS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYMPTOMATOLOGY; TERTIARY CARE CENTER; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DISEASE COURSE; FORCED EXPIRATORY VOLUME; LUNG; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; REGISTER; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STATISTICAL MODEL; TIME FACTOR; VITAL CAPACITY;

AGED; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REGISTRIES; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; VITAL CAPACITY;

EID: 84975270880     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S105583     Document Type: Article

References (28)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease; updated 2014. Available from: http://www.goldcopd.org. Accessed February 5, 2014.
2. Spencer S, Calverley PMA, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23(5):698-702.
3. Soler-Cataluna JJ, Martınez-Garcıa MA, Roman Sanchez P, Salcedo E, Navarro M, Orchando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925-931.
4. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847-852.
5. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117:5S-9S.
6. Korean Academy of Tuberculosis and Respiratory Disease. COPD Guidelines; revised 2012. Available from: http://www.lungkorea.org/thesis/guide.php. Accessed February 5, 2014.
7. Buist AS, McBurnie MA, Vollmer WM, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-750.
8. Menezes AMB, Perez-Padilla R, Jardim JRB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-1881.
9. Hwang YI, Park YB, Oh YM, et al. Comparison of Korean COPD guideline and GOLD Initiative Report in term of acute exacerbation: a validation study for Korean COPD guidelines. J Korean Med Sci. 2014;29(8):1108-1112.
10. Rhee CK, Kim JW, Hwang YI, et al. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1623-1631.
11. Bestall JC, Paul EA, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
12. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654.
13. Mequro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest. 2007;132(2):456-463.
14. Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608-1613.
15. Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-789.
16. Seemungal TAR, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD - a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203-223.
17. Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbations in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
18. Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195-203.
19. Jones PW. St. George’s Respiratory Questionnaire: MCID. COPD. 2005;2(1):75-79.
20. Hwang YI, Lee SH, Yoo JH, et al. History of pneumonia is a strong risk factor for COPD exacerbation in South Korea: the EPOCH study (Epidemiologic review and Prospective Observation of COPD and Health in Korea). J Thorac Dis. 2015;7(12):2203-2213.
21. Mapel DW, Robert MH. Spirometry, the St. George’s Respiratory Questionnaire and other clinical measures as predictors of medical costs and COPD exacerbation events in a prospective cohort. Southwest Respir Crit Care Chron. 2015;3(10):1-9.
22. Osman LM, Godden DJ, Friend JAR, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997;52:67-71.
23. Mullerova H, Maselli DJ, Locantore N, et al. Hospitalized exacerbation of COPD. Risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999-1007.
24. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):680-685.
25. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114-1121.
26. Hayden LP, Hobbs BD, Cohen RT, et al. Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study. Respir Res. 2015;16(1):115.
27. Lopez-Campos JL, Agusti A. Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal. Lancet Respir Med. 2015;3(9):729-734.
28. Yoo KH, Kim YS, Sheen SS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011;16(4):659-665.